BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Marchesi I, Bagella L. Targeting Enhancer of Zeste Homolog 2 as a promising strategy for cancer treatment. World J Clin Oncol 2016; 7(2): 135-148 [PMID: 27081636 DOI: 10.5306/wjco.v7.i2.135]
URL: https://www.wjgnet.com/1007-9327/full/v7/i2/135.htm
Number Citing Articles
1
Yating Xu, Xiao Yu, Zongzong Sun, Yuting He, Wenzhi Guo. Roles of lncRNAs Mediating Wnt/β-Catenin Signaling in HCCFrontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.831366
2
Imlimaong Aier, Pritish Kumar Varadwaj, Utkarsh Raj. Structural insights into conformational stability of both wild-type and mutant EZH2 receptorScientific Reports 2016; 6(1) doi: 10.1038/srep34984
3
Chidimma Agatha Akpa, Karsten Kleo, Dido Lenze, Elisabeth Oker, Lora Dimitrova, Michael Hummel, Francesco Bertolini. DZNep-mediated apoptosis in B-cell lymphoma is independent of the lymphoma type, EZH2 mutation status and MYC, BCL2 or BCL6 translocationsPLOS ONE 2019; 14(8): e0220681 doi: 10.1371/journal.pone.0220681
4
Alexius John, Hazel O’Sullivan, Sanjay Popat. Updates in Management of Malignant Pleural MesotheliomaCurrent Treatment Options in Oncology 2023; 24(12): 1758 doi: 10.1007/s11864-023-01148-2
5
Komal Thapa, Heena Khan, Amarjot Kaur Grewal, Neha Kanojia, Gagandeep Kaur, Parul Sood, Thakur Gurjeet Singh. Insights into the Therapeutic Potential of Phytoconstituents as an Epigenetic Modulators in Diabetic NephropathyCurrent Pharmacology Reports 2023; 9(6): 404 doi: 10.1007/s40495-023-00345-9
6
Arnaud Scherpereel, Frederic Wallyn, Steven M Albelda, Camille Munck. Novel therapies for malignant pleural mesotheliomaThe Lancet Oncology 2018; 19(3): e161 doi: 10.1016/S1470-2045(18)30100-1
7
Arnaud Scherpereel. Chemotherapy for Malignant Pleural Mesothelioma: Past, Present and FutureCurrent Pulmonology Reports 2017; 6(2): 155 doi: 10.1007/s13665-017-0179-7
8
Fabio Nicolini, Martine Bocchini, Giuseppe Bronte, Angelo Delmonte, Massimo Guidoboni, Lucio Crinò, Massimiliano Mazza. Malignant Pleural Mesothelioma: State-of-the-Art on Current Therapies and Promises for the FutureFrontiers in Oncology 2020; 9 doi: 10.3389/fonc.2019.01519
9
Duo Xu, Haitang Yang, Ralph A. Schmid, Ren-Wang Peng. Therapeutic Landscape of Malignant Pleural Mesothelioma: Collateral Vulnerabilities and Evolutionary Dependencies in the SpotlightFrontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.579464
10
Ying Cheng, Ying Li, Xin Huang, Wenbin Wei, Yi Qu. Expression of EZH2 in uveal melanomas patients and associations with prognosisOncotarget 2017; 8(44): 76423 doi: 10.18632/oncotarget.19462
11
Lilong Xia, Xinhai Zhu, Lei Zhang, Yanhui Xu, Guoping Chen, Jing Luo. EZH2 enhances expression of CCL5 to promote recruitment of macrophages and invasion in lung cancerBiotechnology and Applied Biochemistry 2020; 67(6): 1011 doi: 10.1002/bab.1875
12
Hanif Khan, Zhengzhong Ni, Hai Feng, Yaqi Xing, Xuejun Wu, Danmei Huang, Ling Chen, Yongdong Niu, Ganggang Shi. Combination of curcumin with N-n-butyl haloperidol iodide inhibits hepatocellular carcinoma malignant proliferation by downregulating enhancer of zeste homolog 2 (EZH2) - lncRNA H19 to silence Wnt/β-catenin signalingPhytomedicine 2021; 91: 153706 doi: 10.1016/j.phymed.2021.153706
13
Ioannis Anestopoulos, Aristeidis Sfakianos, Rodrigo Franco, Katerina Chlichlia, Mihalis Panayiotidis, David Kroll, Aglaia Pappa. A Novel Role of Silibinin as a Putative Epigenetic Modulator in Human Prostate CarcinomaMolecules 2016; 22(1): 62 doi: 10.3390/molecules22010062
14
Irene Marchesi, Luca Sanna, Milena Fais, Francesco P. Fiorentino, Antonio Giordano, Luigi Bagella. 12‐O‐tetradecanoylphorbol‐13‐acetate and EZH2 inhibition: A novel approach for promoting myogenic differentiation in embryonal rhabdomyosarcoma cellsJournal of Cellular Physiology 2018; 233(3): 2360 doi: 10.1002/jcp.26107
15
Serena Ferraresso, Arianna Aricò, Tiziana Sanavia, Silvia Da Ros, Massimo Milan, Luciano Cascione, Stefano Comazzi, Valeria Martini, Mery Giantin, Barbara Di Camillo, Sandro Mazzariol, Diana Giannuzzi, Laura Marconato, Luca Aresu. DNA methylation profiling reveals common signatures of tumorigenesis and defines epigenetic prognostic subtypes of canine Diffuse Large B-cell LymphomaScientific Reports 2017; 7(1) doi: 10.1038/s41598-017-11724-w
16
Chidimma Agatha Akpa, Karsten Kleo, Elisabeth Oker, Nancy Tomaszewski, Clemens Messerschmidt, Cristina López, Rabea Wagener, Kathrin Oehl-Huber, Katja Dettmer, Anne Schoeler, Dido Lenze, Peter J. Oefner, Dieter Beule, Reiner Siebert, David Capper, Lora Dimitrova, Michael Hummel. Acquired resistance to DZNep-mediated apoptosis is associated with copy number gains of AHCY in a B-cell lymphoma modelBMC Cancer 2020; 20(1) doi: 10.1186/s12885-020-06937-8
17
Yi Zhang, Bo Tang, Jun Song, Shuiping Yu, Yang Li, Huizhao Su, Songqing He. Lnc-PDZD7 contributes to stemness properties and chemosensitivity in hepatocellular carcinoma through EZH2-mediated ATOH8 transcriptional repressionJournal of Experimental & Clinical Cancer Research 2019; 38(1) doi: 10.1186/s13046-019-1106-2
18
A. Scherpereel. Traitement du mésothéliome pleural malin en 2016Revue des Maladies Respiratoires Actualités 2016; 8(5): 445 doi: 10.1016/S1877-1203(16)30135-5
19
Luca Sanna, Irene Marchesi, Mariarosa A. B. Melone, Luigi Bagella. The role of enhancer of zeste homolog 2: From viral epigenetics to the carcinogenesis of hepatocellular carcinomaJournal of Cellular Physiology 2018; 233(9): 6508 doi: 10.1002/jcp.26545
20
Francesco Paolo Fiorentino, Irene Marchesi, Christoph Schröder, Ronny Schmidt, Jun Yokota, Luigi Bagella. BET-Inhibitor I-BET762 and PARP-Inhibitor Talazoparib Synergy in Small Cell Lung Cancer CellsInternational Journal of Molecular Sciences 2020; 21(24): 9595 doi: 10.3390/ijms21249595